Diabetes Mellitus, published by the Endocrinology Research Centre in the Russian Federation, is an esteemed open-access journal dedicated to the field of endocrinology, diabetes, and metabolism. Since its inception in 1998, this journal has been a pivotal platform for disseminating cutting-edge research and comprehensive reviews that address the multifaceted challenges posed by diabetes. With its current quartile ranking of Q4 in Endocrinology and the associated fields, as well as commendable involvement in the broader scope of Internal Medicine, Diabetes Mellitus plays a crucial role in enhancing clinical practices and informing innovative therapeutic strategies. The journal caters to a diverse audience of researchers, healthcare professionals, and students, particularly those seeking to expand their knowledge and improve patient outcomes in diabetes care. With a commitment to fostering scientific conversation and collaboration, Diabetes Mellitus is an invaluable resource for anyone engaged in the fight against diabetes and its complications.

The Journal of Diabetes Science and Technology, published by SAGE Publications Inc, is a premier academic journal that spans vital research and innovative advancements in the fields of diabetes management, bioengineering, and biomedical engineering. With an impressive impact factor reflected in its Q1 rankings across multiple categories such as Bioengineering and Internal Medicine as of 2023, this journal serves as an invaluable resource for researchers, healthcare professionals, and students dedicated to understanding and improving diabetes care and treatment. The journal invites contributions that encompass a wide range of scientific discoveries, methodologies, and technological innovations affecting diabetes and metabolism, ensuring a comprehensive platform for the dissemination of pivotal research findings. Although not an open-access journal, it provides highly curated content that reflects the cutting-edge advancements and emerging trends in diabetes science, making it an essential reference point for the scientific community.

Journal of Clinical and Translational Endocrinology is a peer-reviewed open access journal published by Elsevier that has been serving the endocrinology community since its inception in 2014. With an ISSN of 2214-6237, this journal focuses on the critical intersection of clinical and translational research in endocrinology, diabetes, and metabolism, offering insights that bridge laboratory discoveries with patient care. It holds a commendable position in the field, ranking Q3 for Endocrinology and Q2 for Endocrinology, Diabetes, and Metabolism, reflecting its rigorous standards and relevance to contemporary research. Situated in the Netherlands, the journal’s aim is to foster knowledge dissemination and collaboration among professionals, researchers, and students alike, ensuring high visibility in a rapidly evolving field. The journal is committed to open access, allowing immediate access to research findings, thus maximizing their impact and facilitating advancements in clinical practice and research. With an H index that showcases its contribution to the field, Journal of Clinical and Translational Endocrinology is an essential resource for anyone invested in advancing endocrinological science.

Canadian Journal of Diabetes is a leading peer-reviewed journal published by Elsevier, dedicated to advancing the understanding and management of diabetes and its associated conditions. Established in 2002, this journal serves as an essential resource for researchers, healthcare professionals, and students interested in the field of endocrinology, diabetes, and metabolism, boasting a commendable Impact Factor that signifies its influence in the academic community. With a focus on high-quality research articles, comprehensive reviews, and insightful commentary, the journal's scope encompasses clinical and experimental studies that address the challenges of diabetes care and prevention. Currently ranked in the Q2 category across multiple relevant categories, including Endocrinology and Medicine, the Canadian Journal of Diabetes is crucial for those seeking to stay at the forefront of diabetes research and practice. The journal is indexed in prestigious databases, making it easily accessible to the global academic community. Located in Amsterdam, Netherlands, it reflects the publisher's commitment to promoting innovation and collaboration in medical research.

Diabetes & Metabolic Syndrome-Clinical Research & Reviews is a leading peer-reviewed journal published by ELSEVIER SCI LTD in the field of endocrinology, diabetes, and internal medicine. With an impressive impact factor evidenced by its high rankings, this journal is positioned in the top quartile (Q1) across multiple categories, including Endocrinology, Diabetes and Metabolism, and Internal Medicine. Spanning from 2007 to 2024, it serves as a vital resource for researchers, healthcare professionals, and students alike, offering comprehensive reviews and innovative clinical research related to metabolic disorders. Located in the Netherlands, the journal emphasizes an open-access approach, ensuring valuable insights are available to a global audience. By publishing high-quality and impactful articles, Diabetes & Metabolic Syndrome not only contributes to the advancement of scientific knowledge but also plays a crucial role in shaping clinical practices and enhancing patient care in the realm of diabetes and metabolic syndrome.

BMJ Open Diabetes Research & Care is a premier open access journal published by the BMJ PUBLISHING GROUP, dedicated to advancing the field of diabetes research and care. With an impressive impact factor and positioned in the Q1 category of Endocrinology, Diabetes and Metabolism, this journal serves as a vital resource for researchers, clinicians, and healthcare professionals striving to improve diabetes management and treatment strategies. Since its inception in 2014, the journal has provided an accessible platform for high-quality, peer-reviewed research, ensuring global outreach and dissemination of groundbreaking findings in diabetes care. With Scopus ranking it at #35 out of 244 in its field, reflecting an 85th percentile ranking, BMJ Open Diabetes Research & Care remains committed to fostering innovation and discourse within the diabetes community. This journal not only publishes original research articles but also invites systematic reviews, clinical studies, and comprehensive reviews, aiming to address the pressing challenges faced in diabetes care today.

Revista Portuguesa de Endocrinologia Diabetes e Metabolismo is a pivotal journal dedicated to advancing the fields of endocrinology, diabetes, and metabolism. Published by the esteemed SOC PORTUGUESA ENDOCRINOLOGIA, DIABETES & METABOLISMO-SPEDM, this journal serves as a platform for the dissemination of high-quality research, clinical studies, and innovative practices within these related disciplines. With a commitment to providing insightful and impactful content, the journal aims to foster knowledge sharing among researchers, healthcare professionals, and students interested in the latest developments in endocrine disorders and metabolic diseases. Although currently not open access, the journal's comprehensive approach and rigorous peer-review process ensure that it remains a respected source of information for its readers in Portugal and beyond. With its address rooted in the heart of Lisbon, the Revista Portuguesa de Endocrinologia Diabetes e Metabolismo plays a vital role in enhancing the understanding and treatment of endocrine and metabolic conditions in the modern healthcare landscape.

Lancet Diabetes & Endocrinology is a premier peer-reviewed journal, published by Elsevier Science Inc, dedicated to advancing the fields of endocrinology, diabetes, and metabolism. Established in 2013, this journal has quickly ascended to a position of notable prestige, reflected in its prestigious Q1 rank across various categories, including Endocrinology, Internal Medicine, and Diabetes & Metabolism. With an impressive impact factor and Scopus rankings placing it in the 99th percentile of its field, it serves as a vital resource for researchers, healthcare professionals, and students alike. The journal aims to disseminate high-quality research covering clinical and experimental aspects of metabolic and endocrine disorders, making it an indispensable tool for those looking to stay at the forefront of these rapidly evolving fields. With its focus on innovative depth and cutting-edge studies, Lancet Diabetes & Endocrinology continually fosters an international dialogue critical for advancements in diabetes and endocrinology.

Diabetes Technology & Therapeutics is a leading journal published by MARY ANN LIEBERT, INC, dedicated to advancing the field of diabetes management through innovative technologies and therapeutic strategies. With an impressive impact factor and recognized as a Q1 journal in Endocrinology, Diabetes and Metabolism, as well as Medical Laboratory Technology, it occupies a pivotal position in the academic landscape. This esteemed publication features a comprehensive range of articles that cover cutting-edge research, clinical applications, and developments in diabetes care from 1999 to 2024, making it a critical resource for researchers, health professionals, and students alike. The journal is committed to fostering dialogue between disciplines, especially given its strong rankings in various scientific categories including the 98th percentile in Medical Laboratory Technology. By opting for subscription-based access, readers gain insight into the latest innovations that are shaping diabetes technology and treatment paradigms, thereby enhancing patient outcomes and advancing the scientific community's understanding of this complex disease.

Current Diabetes Reports is a leading academic journal published by CURRENT MEDICINE GROUP, dedicated to advancing research and clinical practices in the field of diabetes and endocrinology. With an impressive impact factor and ranked in the prestigious Q1 category for both Endocrinology, Diabetes and Metabolism and Internal Medicine, this journal serves as a vital resource for researchers, clinicians, and students alike. Established in 2001 and converging years up to 2024, Current Diabetes Reports aims to disseminate high-quality, peer-reviewed research articles, reviews, and clinical studies that address the multifaceted challenges of diabetes management and treatment. As it continues to thrive within a robust international community, the journal provides critical insights that are essential for improving patient outcomes and informing public health policies in the United States and beyond.